Logo

Melodie Darwin · 10-31-2012, 04:24 AM

Romney’s lax regulation may have fueled meningitis outbreak - Salon.com

Quote:

But the epidemic may also play a role in the presidential campaign, now that state records reveal that a Massachusetts regulatory agency found that the New England Compounding Co., the pharmaceutical company tied to the epidemic, repeatedly failed to meet accepted standards in 2004 — but a reprimand was withdrawn by the Romney administration in apparent deference to the company’s business interests.

According to the news this morning, Michigan has 62 cases and 8 deaths so far. I am really hoping Attorney Geoffrey Fieger included Romney in his lawsuit as he should be accountable for what happened.

**Cristiano** · 10-31-2012, 05:23 AM

Unlike the commercial where the wife of the worker laid off by Bain died of cancer, there is a direct contributory link here through negligence.

Melodie Darwin · 10-31-2012, 05:53 AM

Quote:

Originally Posted by Cristiano

Unlike the commercial where the wife of the worker laid off by Bain died of cancer, there is a direct contributory link here through negligence.

One of the contributing factors to why this outbreak has been so bad is that the hospitals had no idea what was causing it. I am wondering how easily the lax regulations allowed the company to hide the previous case (cases?) while it "self regulated".

Jahar Aabye · 10-31-2012, 08:28 AM

Scott Gravura at Science Based Medicine has a good summary of the regulatory issues involved in the case, including the differences in how compounding pharmacies are treated differently from pharmaceutical manufacturers.

Two of the problem that played a role are the lack of federal regulation (which leaves it up to states, who may well see an incentive to being "business friendly" to keep jobs in-state) and the fact that these compounding pharmacies are supposed to be creating these compounds by individual prescription. When they began manufacturing large batches and shipping them out to be dispensed as-needed, they crossed the line from compounding pharmacy to pharmaceutical manufacturer, but were able to retain the much less strict regulatory standards of the former.

Science-Based Medicine » Weak drug regulation and patient tragedies: We’ve seen this story before

10-31-2012, 08:28 AM	#4 (permalink)
Jahar Aabye Script Kitty Join Date: Sep 2008 Location: Between our dreams and actions, lies this world Posts: 8,028 SL Join Date: 2/16/2007 Business: Black Operations Client: Singularity	Scott Gravura at Science Based Medicine has a good summary of the regulatory issues involved in the case, including the differences in how compounding pharmacies are treated differently from pharmaceutical manufacturers. Two of the problem that played a role are the lack of federal regulation (which leaves it up to states, who may well see an incentive to being "business friendly" to keep jobs in-state) and the fact that these compounding pharmacies are supposed to be creating these compounds by individual prescription. When they began manufacturing large batches and shipping them out to be dispensed as-needed, they crossed the line from compounding pharmacy to pharmaceutical manufacturer, but were able to retain the much less strict regulatory standards of the former. Science-Based Medicine » Weak drug regulation and patient tragedies: We’ve seen this story before __________________ He pulled a Captain Ahab and Jaharpwn'ed her. - Trout

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Logo

Site Navigation